The HDAC1 inhibitor entinostat blocks the growth of CBFβ–MYH11-positive leukemia cells and promotes their differentiation, indicating that HDAC inhibitors may be useful for treatment of inv(16) AML [216]. Here, MYH11 is linked to acute myeloid leukemia.